EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMixed-Methods-StudieOpen Access

Quality of life outcomes and patient-reported experiences in a randomised controlled trial for rifampicin-resistant TB (PRACTECAL-PRO): a mixed-methods study

K Lowton iD, B Stringer iD, M Cusinato iD, K Fielding iD, I Liverko iD, R Moodliar iD, T Z Nikolaevna iD, V Solodovnikova iD, E Kazounis, B-T Nyang'wa iD

IJTLD Open · 2026-05 · 3 (5) · 319-326

DOI: 10.5588/ijtldopen.25.0823 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift IJTLD Open, online erschienen am 01.05.2026. Verfasst von K Lowton und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Sociology and Criminology, University of Sussex, Brighton, UK. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND The TB-PRACTECAL clinical trial assessed 24-week, all-oral bedaquiline, pretomanid, and linezolid (BPaL)-based regimens for rifampicin-resistant TB against standard of care (SoC). The PRACTECAL-PRO sub-study evaluated changes in quality of life (QoL), among patients receiving investigational regimens versus SoC, and assessed patient experiences of the new treatments. METHODS We recruited participants from Belarus, Uzbekistan, and South Africa. Changes in QoL from baseline to 48 weeks were evaluated using the Short Form-12 (SF-12) and the St George’s Respiratory Questionnaire (SGRQ). Longitudinal analysis was conducted for all six domains of SF-12 and SGRQ. In-depth interviews provided narratives about patients’ experiences. RESULTS 137 patients participated in PRACTICAL-PRO. All trial arms showed improved SF-12 and SGRQ scores over 48 weeks. Proportional reduction in scores for SGRQ per month was higher in investigational than SoC groups’ Total score (13% vs. 4%), Impact (12% vs. 2%), Activity (14% vs. 7%), and Symptom (15% vs. 4%) domains, indicating quicker QoL improvement. Narratives indicated early treatment satisfaction and social acceptance, with wellbeing relying on family support, clinical contact, and counselling. CONCLUSION Patients receiving short, all-oral BPaL-based regimens show improvements across all measured QoL domains, a positive impact on personal relationships, and a return to productive life. TB trials should routinely include patient-reported outcomes.

Schlagwörter

Stichwörter der Autor:innen

QoLRR-TBclinical trialdrug-resistant TBpatient experiencespatient-reported outcomestuberculosis

Autor:innen und Institutionen

  • Department of Sociology and Criminology, University of Sussex, Brighton, UK.
  • Manson Unit, Médecins Sans Frontières, London, UK.
  • TB centre, London School of Hygiene and Tropical Medicine, London, UK.
  • Republican Specialized Scientific Research Medical Centre of Phisiology and Pulmonology (TB Institute), Tashkent, Uzbekistan.
  • THINK (TB&HIV Investigative Network), Doris Goodwin Hospital, Pietermaritzburg and Hillcrest, Durban, South Africa.
  • Nukus TB Hospital and Out-Patient Department, Nukus, Uzbekistan.

ORCID-Profile: K Lowton, B Stringer, M Cusinato, K Fielding, I Liverko, R Moodliar, T Z Nikolaevna, V Solodovnikova, B-T Nyang'wa

Zitieren

APA

Lowton, K., Stringer, B., Cusinato, M., Fielding, K., Liverko, I., Moodliar, R., Nikolaevna, T. Z., Solodovnikova, V., Kazounis, E., & Nyang'wa, B. T. (2026). Quality of life outcomes and patient-reported experiences in a randomised controlled trial for rifampicin-resistant TB (PRACTECAL-PRO): a mixed-methods study. IJTLD Open, 3(5), 319-326. https://doi.org/10.5588/ijtldopen.25.0823

Vancouver

Lowton K, Stringer B, Cusinato M, Fielding K, Liverko I, Moodliar R, et al. Quality of life outcomes and patient-reported experiences in a randomised controlled trial for rifampicin-resistant TB (PRACTECAL-PRO): a mixed-methods study. IJTLD Open. 2026;3(5):319-326. doi:10.5588/ijtldopen.25.0823

BibTeX
@article{Lowton2026,
  author = {Lowton, K and Stringer, B and Cusinato, M and Fielding, K and Liverko, I and Moodliar, R and Nikolaevna, T Z and Solodovnikova, V and Kazounis, E and Nyang'wa, B-T},
  title = {Quality of life outcomes and patient-reported experiences in a randomised controlled trial for rifampicin-resistant TB (PRACTECAL-PRO): a mixed-methods study},
  journal = {IJTLD Open},
  year = {2026},
  volume = {3},
  number = {5},
  pages = {319--326},
  doi = {10.5588/ijtldopen.25.0823}
}
Kostenlos starten →